James F. Oliviero III
2015
In 2015, James F. Oliviero III earned a total compensation of $2.9M as Chief Executive Officer and President at Checkpoint Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $43,288 |
|---|---|
| Salary | $86,986 |
| Stock Awards | $2,773,331 |
| Total | $2,903,605 |
Oliviero received $2.8M in stock awards, accounting for 96% of the total pay in 2015.
Oliviero also received $43.3K in non-equity incentive plan and $87K in salary.
Rankings
In 2015, James F. Oliviero III's compensation ranked 3,292nd out of 13,638 executives tracked by ExecPay. In other words, Oliviero earned more than 75.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,292 out of 13,638 | 76th |
Division Manufacturing | 1,199 out of 5,190 | 77th |
Major group Chemicals And Allied Products | 438 out of 1,854 | 76th |
Industry group Drugs | 348 out of 1,528 | 77th |
Industry Pharmaceutical Preparations | 277 out of 1,182 | 77th |
Source: SEC filing on April 28, 2017.
News
Checkpoint Therapeutics CEO James Oliviero's 2023 pay slips 20% to $1.6M
April 2, 2024
Checkpoint Therapeutics CEO James Oliviero's 2022 pay slips 11% to $2M
May 1, 2023
Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
April 29, 2022
Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
April 30, 2021
Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
April 24, 2020
Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
April 30, 2019